President Donald Trump issued an executive order (EO) aimed at drastically reducing the cost of prescription drugs for ...

UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...

President Donald Trump's drug pricing order seeks to balance innovation with affordability, ending the burden on American patients and ensuring fair global contributions.

The federal government and policy experts say potential impacts from Trump's order, including supply shortages and higher ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...

KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

On May 11, the day before President Donald Trump held a White House event to sign the executive order, he posted on Truth ...